Private Market View

Convergent Therapeutics

Drug Discovery · Cambridge, MA · Founded 2020 · Privately Held (backing)

Last price · $/share
Implied valuation
$280.0M
Total raised
$130.0M
Last round
Early Stage VC
Jul 2024
How much has Convergent Therapeutics raised?
$130.0Macross 2 recorded rounds · May 2023Jul 2024

Most recently, Convergent Therapeutics raised $22.2M in its Early Stage VC (Jul 2024).

Free account
See the evidence behind this price
  • ·Post-money valuations for all 2 rounds
  • ·The complete investor list — 4 names
  • ·Watchlist + deal alerts for Convergent Therapeutics
Create free account
No card required

Round by round

2 rounds
Jul 2024Early Stage VC$22.2MSEC filing
1 investors participated
May 2023Early Stage VC (Series A)$90.0M
+ 1 more investors · free account
For fundraisers
Raising for a company like Convergent Therapeutics?

4 investors have backed Convergent Therapeutics — start your target list with the firms already writing checks in drug discovery.

See all 4 investors →

Frequently asked

How much has Convergent Therapeutics raised?
Convergent Therapeutics has raised $130.0M in total across 2 recorded funding rounds.
When was Convergent Therapeutics's last funding round?
Convergent Therapeutics's most recent recorded round was Early Stage VC in Jul 2024, raising $22.2M.